Showing 1 - 6 of 6
Unwinding the Dr Boon scandal
Business, Nuntawun Polkuamdee, Published on 14/12/2024
» Investor confidence was still recovering from recent stock market manipulations when a high-profile investment scam involving Dr Boon Vanasin, an 86-year-old hospital veteran, sent shockwaves throughout Thailand's business arena, causing damages of nearly 8 billion baht.
THG chief case referred to Amlo
Business, Nuntawun Polkuamdee, Published on 16/12/2022
» The Securities and Exchange Commission (SEC) has referred the case of Dr Boon Vanasin, former chairman of SET-listed Thonburi Healthcare Group (THG), to the Anti-Money Laundering Office for further investigation.
SEC probes THG vaccine mystery
Business, Nuntawun Polkuamdee, Published on 05/08/2021
» The Securities and Exchange Commission (SEC) on Wednesday ordered Thonburi Healthcare Group (THG) and its chairman Boon Vanasin to clarify certain facts within seven days regarding his recently scrapped plans to import Pfizer Covid-19 vaccines into Thailand.
Boon probed for THG purchases
Business, Nuntawun Polkuamdee, Published on 17/07/2021
» Thailand's stock and securities authorities are preparing to investigate irregular trading transactions by the head of Thonburi Healthcare Group (THG), Dr Boon Vanasin, prior to an announcement by the hospital it would make a major purchase of mRNA Covid-19 vaccines.
Stock beneficiaries in private healthcare
Business, Nuntawun Polkuamdee, Published on 19/04/2021
» The stock prices of private hospitals are likely to increase given the new outbreak, say analysts from Capital Nomura Securities (CNS) and Trinity Securities, citing a 200-300% increase in people seeking Covid-19 tests per day.
Hospital stocks poised to rise
Business, Nuntawun Polkuamdee, Published on 10/03/2021
» Hospital stocks are set to rise following the government decision to reduce quarantine time from 14 days to 7-10 days as more foreign patients will likely return for treatment after the easing, says KTBST Securities (KTBST).